The LR+ of the ELISA was 94, meaning that a MAT-reactive serum sample is 94 times more likely to have a positive test than a person without the disease. The LR2
(people who are disease negative and test negative) was 0.05. Agreement between the ELISA and MAT was excellent, with a k score of 0.90 (95 % CI 0.82–0.98).